Healthcare and Pharmaceuticals industry

Parkinsons Disease Drug Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Parkinson's Disease Drug Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

Parkinson's disease is a progressive neurodegenerative disorder characterized by loss of movement and muscular rigidity. The symptoms of Parkinson’s disease are usually apparent in childhood but can also occur later in life as well. It is often referred to as the 'disease of despair. Symptoms may include loss of grip on the upper limbs or decreased ability to walk.

Increasing prevalence of Parkinson's disease around the globe is propelling the market growth of the Parkinson's disease drug. According to the Parkinson's Foundation, more than 10 million people worldwide are living with PD. Nearly one million will be living with Parkinson's disease (PD) in the U.S. by 2020. Moreover, the increasing geriatric population as the incidence of this disease increase with the age is again driving the market growth of Parkinson’s disease drug over the forecast period. According to the United Nation, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%).

From the geographical point of view, North America is expected to gain significant growth over the forecast period and this is attributed to increasing healthcare costs on Parkinson’s disease treatment. According to the American Parkinson Disease Association, the total cost of Parkinson’s disease is $52 billion every year, with $25.4 billion attributable to direct medical costs, and $26.5 billion attributable to indirect medical costs. Of that total cost, $25 billion is shouldered by the federal government through Social Security and Medicare programs.

Key Developments:

  1. In August 2019, The U.S. Food and Drug Administration approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing "off" episodes.
  2. In June 2019, Rusan Pharma announced the launch of APOSAN -Apomorphine Hydrochloride (HCl). APOSAN is used for the treatment of motor fluctuations (ON-OFF) in patients with Parkinson’s disease (PD)
  3. In October 2020, SK Chemical has announced the launch of Ongentis, a Parkinson's disease treatment developed by a Portuguese pharmaceutical firm Bial
  4. In October 2020, Sunovion announced the launch of its apomorphine hydrochloride (Kynmobi) sublingual film for the acute intermittent treatment of “off” episodes in patients with Parkinson disease (PD)
  5. In April 2017, Italian pharmaceutical company Zambon and its partner Newron Pharmaceuticals have launched Xadago (safinamide) in Portugal to treat mid-to-late stage Parkinson’s disease (PD).
  6. In July 2018, UCB announced approval of NEUPRO® in China for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease

The Parkinsons Disease Drug Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Parkinsons Disease Drug Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Teva
  • Novartis AG
  • GSK
  • AbbVie
  • Merck
  • Boehringer Ingelheim
  • Impax Laboratories
  • Lundbeck
  • Sun Pharma
  • Wockhardt
  • UCB
  • Bausch Health
  • Acadia

By the Product Type, the market is primarily segmented into:

  • Carbidopa/Levodopa
  • Dopamine Receptor Agonists
  • MAO-Inhibitors

By Applications, the market is segmented into:

  • Hospital
  • Online
  • Retail Pharmacies

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Parkinsons Disease Drug Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Parkinsons Disease Drug Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Parkinsons Disease Drug Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Parkinsons Disease Drug Market

The Parkinsons Disease Drug Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Parkinsons Disease Drug Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Parkinsons disease Drug Market Overview
1.1 Product Overview and Scope of Parkinsons disease Drug
1.2 Parkinsons disease Drug Segment by Type
1.2.1 Global Parkinsons disease Drug Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Parkinsons disease Drug Segment by Application
1.3.1 Parkinsons disease Drug Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Online
1.3.4 Retail Pharmacies
1.4 Global Parkinsons disease Drug Market by Region
1.4.1 Global Parkinsons disease Drug Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Parkinsons disease Drug Market Size
1.5.1 Global Parkinsons disease Drug Revenue (2014-2025)
1.5.2 Global Parkinsons disease Drug Production (2014-2025)

2 Global Parkinsons disease Drug Market Competition by Manufacturers
2.1 Global Parkinsons disease Drug Production Market Share by Manufacturers (2014-2019)
2.2 Global Parkinsons disease Drug Revenue Share by Manufacturers (2014-2019)
2.3 Global Parkinsons disease Drug Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Parkinsons disease Drug Production Sites, Area Served, Product Types
2.5 Parkinsons disease Drug Market Competitive Situation and Trends
2.5.1 Parkinsons disease Drug Market Concentration Rate
2.5.2 Parkinsons disease Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Parkinsons disease Drug Production Market Share by Regions
3.1 Global Parkinsons disease Drug Production Market Share by Regions
3.2 Global Parkinsons disease Drug Revenue Market Share by Regions (2014-2019)
3.3 Global Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Parkinsons disease Drug Production
3.4.1 North America Parkinsons disease Drug Production Growth Rate (2014-2019)
3.4.2 North America Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Parkinsons disease Drug Production
3.5.1 Europe Parkinsons disease Drug Production Growth Rate (2014-2019)
3.5.2 Europe Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Parkinsons disease Drug Production
3.6.1 China Parkinsons disease Drug Production Growth Rate (2014-2019)
3.6.2 China Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Parkinsons disease Drug Production
3.7.1 Japan Parkinsons disease Drug Production Growth Rate (2014-2019)
3.7.2 Japan Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Parkinsons disease Drug Consumption by Regions
4.1 Global Parkinsons disease Drug Consumption by Regions
4.2 North America Parkinsons disease Drug Consumption (2014-2019)
4.3 Europe Parkinsons disease Drug Consumption (2014-2019)
4.4 China Parkinsons disease Drug Consumption (2014-2019)
4.5 Japan Parkinsons disease Drug Consumption (2014-2019)

5 Global Parkinsons disease Drug Production, Revenue, Price Trend by Type
5.1 Global Parkinsons disease Drug Production Market Share by Type (2014-2019)
5.2 Global Parkinsons disease Drug Revenue Market Share by Type (2014-2019)
5.3 Global Parkinsons disease Drug Price by Type (2014-2019)
5.4 Global Parkinsons disease Drug Production Growth by Type (2014-2019)

6 Global Parkinsons disease Drug Market Analysis by Applications
6.1 Global Parkinsons disease Drug Consumption Market Share by Application (2014-2019)
6.2 Global Parkinsons disease Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Parkinsons disease Drug Business
7.1 Teva
7.1.1 Teva Parkinsons disease Drug Production Sites and Area Served
7.1.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.1.3 Teva Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Novartis AG
7.2.1 Novartis AG Parkinsons disease Drug Production Sites and Area Served
7.2.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.2.3 Novartis AG Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 GSK
7.3.1 GSK Parkinsons disease Drug Production Sites and Area Served
7.3.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.3.3 GSK Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 AbbVie
7.4.1 AbbVie Parkinsons disease Drug Production Sites and Area Served
7.4.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.4.3 AbbVie Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Merck
7.5.1 Merck Parkinsons disease Drug Production Sites and Area Served
7.5.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.5.3 Merck Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Parkinsons disease Drug Production Sites and Area Served
7.6.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.6.3 Boehringer Ingelheim Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Impax Laboratories
7.7.1 Impax Laboratories Parkinsons disease Drug Production Sites and Area Served
7.7.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.7.3 Impax Laboratories Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.8 Lundbeck
7.8.1 Lundbeck Parkinsons disease Drug Production Sites and Area Served
7.8.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.8.3 Lundbeck Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Sun Pharma
7.9.1 Sun Pharma Parkinsons disease Drug Production Sites and Area Served
7.9.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.9.3 Sun Pharma Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Wockhardt
7.10.1 Wockhardt Parkinsons disease Drug Production Sites and Area Served
7.10.2 Parkinsons disease Drug Product Introduction, Application and Specification
7.10.3 Wockhardt Parkinsons disease Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 UCB
7.12 Bausch Health
7.13 Acadia

8 Parkinsons disease Drug Manufacturing Cost Analysis
8.1 Parkinsons disease Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Parkinsons disease Drug
8.4 Parkinsons disease Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Parkinsons disease Drug Distributors List
9.3 Parkinsons disease Drug Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Parkinsons disease Drug Market Forecast
11.1 Global Parkinsons disease Drug Production, Revenue Forecast
11.1.1 Global Parkinsons disease Drug Production Growth Rate Forecast (2019-2025)
11.1.2 Global Parkinsons disease Drug Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Parkinsons disease Drug Price and Trend Forecast (2019-2025)
11.2 Global Parkinsons disease Drug Production Forecast by Regions (2019-2025)
11.2.1 North America Parkinsons disease Drug Production, Revenue Forecast (2019-2025)
11.2.2 Europe Parkinsons disease Drug Production, Revenue Forecast (2019-2025)
11.2.3 China Parkinsons disease Drug Production, Revenue Forecast (2019-2025)
11.2.4 Japan Parkinsons disease Drug Production, Revenue Forecast (2019-2025)
11.3 Global Parkinsons disease Drug Consumption Forecast by Regions (2019-2025)
11.3.1 North America Parkinsons disease Drug Consumption Forecast (2019-2025)
11.3.2 Europe Parkinsons disease Drug Consumption Forecast (2019-2025)
11.3.3 China Parkinsons disease Drug Consumption Forecast (2019-2025)
11.3.4 Japan Parkinsons disease Drug Consumption Forecast (2019-2025)
11.4 Global Parkinsons disease Drug Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Parkinsons disease Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures

Figure Picture of Parkinsons disease Drug
Table Global Parkinsons disease Drug Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Parkinsons disease Drug Production Market Share by Types in 2018
Figure Carbidopa/Levodopa Product Picture
Table Carbidopa/Levodopa Major Manufacturers
Figure Dopamine Receptor Agonists Product Picture
Table Dopamine Receptor Agonists Major Manufacturers
Figure MAO-Inhibitors Product Picture
Table MAO-Inhibitors Major Manufacturers
Table Global Parkinsons disease Drug Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Parkinsons disease Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Online
Figure Retail Pharmacies
Table Parkinsons disease Drug Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Parkinsons disease Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Parkinsons disease Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Parkinsons disease Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Parkinsons disease Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Parkinsons disease Drug Revenue (Million USD) (2014-2025)
Figure Global Parkinsons disease Drug Production (K Doses) (2014-2025)
Table Global Parkinsons disease Drug Production (K Doses) of Key Manufacturers (2014-2019)
Table Global Parkinsons disease Drug Production Share by Manufacturers (2014-2019)
Figure Parkinsons disease Drug Production Share by Manufacturers in 2018
Table Global Parkinsons disease Drug Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Parkinsons disease Drug Revenue Share by Manufacturers (2014-2019)
Figure Global Parkinsons disease Drug Revenue Share by Manufacturers in 2018
Table Global Market Parkinsons disease Drug Average Price (USD/Dose) of Key Manufacturers (2014-2019)
Figure Global Market Parkinsons disease Drug Average Price (USD/Dose) of Key Manufacturers in 2018
Table Manufacturers Parkinsons disease Drug Production Sites and Area Served
Table Manufacturers Parkinsons disease Drug Product Types
Figure Parkinsons disease Drug Market Share of Top 5 Manufacturers
Figure Parkinsons disease Drug Market Share of Top 10 Manufacturers
Table Global Parkinsons disease Drug Production (K Doses) by Region (2014-2019)
Table Global Parkinsons disease Drug Production Market Share by Region (2014-2019)
Figure Global Parkinsons disease Drug Production Market Share by Region (2014-2019)
Figure Global Parkinsons disease Drug Production Market Share by Region in 2018
Table Global Parkinsons disease Drug Revenue (Million USD) by Region (2014-2019)
Table Global Parkinsons disease Drug Revenue Market Share by Region (2014-2019)
Figure Global Parkinsons disease Drug Revenue Market Share by Region (2014-2019)
Figure Global Parkinsons disease Drug Revenue Market Share by Region in 2018
Figure Global Parkinsons disease Drug Production (K Doses) Growth Rate (2014-2019)
Table Global Parkinsons disease Drug Production (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Figure North America Parkinsons disease Drug Production (K Doses) Growth Rate (2014-2019)
Table North America Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Europe Parkinsons disease Drug Production (K Doses) Growth Rate (2014-2019)
Table Europe Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure China Parkinsons disease Drug Production (K Doses) Growth Rate (2014-2019)
Table China Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Japan Parkinsons disease Drug Production (K Doses) Growth Rate (2014-2019)
Table Japan Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Global Parkinsons disease Drug Consumption (K Doses) Market by Region (2014-2019)
Table Global Parkinsons disease Drug Consumption Market Share by Region (2014-2019)
Figure Global Parkinsons disease Drug Consumption Market Share by Region (2014-2019)
Figure Global Parkinsons disease Drug Consumption Market Share by Region in 2018
Figure North America Parkinsons disease Drug Consumption Growth Rate (2014-2019) (K Doses)
Figure Europe Parkinsons disease Drug Consumption Growth Rate (2014-2019) (K Doses)
Figure China Parkinsons disease Drug Consumption Growth Rate (2014-2019) (K Doses)
Figure Japan Parkinsons disease Drug Consumption Growth Rate (2014-2019) (K Doses)
Table Global Parkinsons disease Drug Production (K Doses) by Type (2014-2019)
Table Global Parkinsons disease Drug Production Share by Type (2014-2019)
Figure Production Market Share of Parkinsons disease Drug by Type (2014-2019)
Figure Production Market Share of Parkinsons disease Drug by Type in 2018
Table Global Parkinsons disease Drug Revenue (Million USD) by Type (2014-2019)
Table Global Parkinsons disease Drug Revenue Share by Type (2014-2019)
Figure Revenue Share of Parkinsons disease Drug by Type (2014-2019)
Figure Revenue Market Share of Parkinsons disease Drug by Type in 2018
Table Global Parkinsons disease Drug Price (USD/Dose) by Type (2014-2019)
Figure Global Parkinsons disease Drug Production Growth by Type (2014-2019) (K Doses)
Table Global Parkinsons disease Drug Consumption (K Doses) by Application (2014-2019)
Table Global Parkinsons disease Drug Consumption Market Share by Application (2014-2019)
Figure Global Parkinsons disease Drug Consumption Market Share by Applications (2014-2019)
Figure Global Parkinsons disease Drug Consumption Market Share by Application in 2018
Table Global Parkinsons disease Drug Consumption Growth Rate by Application (2014-2019)
Figure Global Parkinsons disease Drug Consumption Growth Rate by Application (2014-2019)
Table Teva Parkinsons disease Drug Production Sites and Area Served
Table Teva Product Introduction, Application and Specification
Table Teva Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Teva Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure Teva Parkinsons disease Drug Production Market Share (2014-2019)
Figure Teva Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Teva Main Business and Markets Served
Table Novartis AG Parkinsons disease Drug Production Sites and Area Served
Table Novartis AG Product Introduction, Application and Specification
Table Novartis AG Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Novartis AG Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure Novartis AG Parkinsons disease Drug Production Market Share (2014-2019)
Figure Novartis AG Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Novartis AG Main Business and Markets Served
Table GSK Parkinsons disease Drug Production Sites and Area Served
Table GSK Product Introduction, Application and Specification
Table GSK Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure GSK Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure GSK Parkinsons disease Drug Production Market Share (2014-2019)
Figure GSK Parkinsons disease Drug Revenue Market Share (2014-2019)
Table GSK Main Business and Markets Served
Table AbbVie Parkinsons disease Drug Production Sites and Area Served
Table AbbVie Product Introduction, Application and Specification
Table AbbVie Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure AbbVie Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure AbbVie Parkinsons disease Drug Production Market Share (2014-2019)
Figure AbbVie Parkinsons disease Drug Revenue Market Share (2014-2019)
Table AbbVie Main Business and Markets Served
Table Merck Parkinsons disease Drug Production Sites and Area Served
Table Merck Product Introduction, Application and Specification
Table Merck Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Merck Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure Merck Parkinsons disease Drug Production Market Share (2014-2019)
Figure Merck Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Merck Main Business and Markets Served
Table Boehringer Ingelheim Parkinsons disease Drug Production Sites and Area Served
Table Boehringer Ingelheim Product Introduction, Application and Specification
Table Boehringer Ingelheim Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Boehringer Ingelheim Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure Boehringer Ingelheim Parkinsons disease Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Main Business and Markets Served
Table Impax Laboratories Parkinsons disease Drug Production Sites and Area Served
Table Impax Laboratories Product Introduction, Application and Specification
Table Impax Laboratories Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Impax Laboratories Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure Impax Laboratories Parkinsons disease Drug Production Market Share (2014-2019)
Figure Impax Laboratories Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Impax Laboratories Main Business and Markets Served
Table Lundbeck Parkinsons disease Drug Production Sites and Area Served
Table Lundbeck Product Introduction, Application and Specification
Table Lundbeck Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Lundbeck Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure Lundbeck Parkinsons disease Drug Production Market Share (2014-2019)
Figure Lundbeck Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Lundbeck Main Business and Markets Served
Table Sun Pharma Parkinsons disease Drug Production Sites and Area Served
Table Sun Pharma Product Introduction, Application and Specification
Table Sun Pharma Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Sun Pharma Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure Sun Pharma Parkinsons disease Drug Production Market Share (2014-2019)
Figure Sun Pharma Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Sun Pharma Main Business and Markets Served
Table Wockhardt Parkinsons disease Drug Production Sites and Area Served
Table Wockhardt Product Introduction, Application and Specification
Table Wockhardt Parkinsons disease Drug Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Wockhardt Parkinsons disease Drug Production Growth Rate (2014-2019)
Figure Wockhardt Parkinsons disease Drug Production Market Share (2014-2019)
Figure Wockhardt Parkinsons disease Drug Revenue Market Share (2014-2019)
Table Wockhardt Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinsons disease Drug
Figure Manufacturing Process Analysis of Parkinsons disease Drug
Figure Parkinsons disease Drug Industrial Chain Analysis
Table Parkinsons disease Drug Distributors List
Table Parkinsons disease Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Parkinsons disease Drug Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Global Parkinsons disease Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Parkinsons disease Drug Price and Trend Forecast (2019-2025)
Table Global Parkinsons disease Drug Production (K Doses) Forecast by Region (2019-2025)
Figure Global Parkinsons disease Drug Production Market Share Forecast by Region (2019-2025)
Figure North America Parkinsons disease Drug Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure North America Parkinsons disease Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Parkinsons disease Drug Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Europe Parkinsons disease Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Parkinsons disease Drug Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure China Parkinsons disease Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Parkinsons disease Drug Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Japan Parkinsons disease Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Parkinsons disease Drug Consumption (K Doses) Forecast by Regions (2019-2025)
Figure Global Parkinsons disease Drug Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Parkinsons disease Drug Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Europe Parkinsons disease Drug Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure China Parkinsons disease Drug Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Japan Parkinsons disease Drug Consumption (K Doses) Growth Rate Forecast (2019-2025)
Table Global Parkinsons disease Drug Production (K Doses) Forecast by Type (2019-2025)
Figure Global Parkinsons disease Drug Production (K Doses) Forecast by Type (2019-2025)
Table Global Parkinsons disease Drug Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Parkinsons disease Drug Revenue Market Share Forecast by Type (2019-2025)
Table Global Parkinsons disease Drug Price (USD/Dose) Forecast by Type (2019-2025)
Table Global Parkinsons disease Drug Consumption (K Doses) Forecast by Application (2019-2025)
Figure Global Parkinsons disease Drug Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.